Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loek van Alphen

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Infection and Immunity|October 24, 2003
Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation formThomas A Luijkx, Harry van Dijken, Hendrik-Jan Hamstra, et al.
Vaccine|September 15, 2004
Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteinsMarien I de Jonge, Hendrik Jan Hamstra, Wim Jiskoot, et al.
European Journal of Biochemistry|October 24, 2002
Conformational analysis of opacity proteins from Neisseria meningitidisMarien I de Jonge, Martine P Bos, Hendrik J Hamstra, et al.
Journal of Medical Microbiology|April 6, 2001
Influence of infection of cells with bacteria associated with reactive arthritis on the peptide repertoire presented by HLA-B27Jeffrey H Ringrose, Anton O Muijsers, Yvonne Pannekoek, et al.
Journal of Molecular Biology|May 6, 2003
Immunogenicity of peptide-vaccine candidates predicted by molecular dynamics simulationsClasien J Oomen, Peter Hoogerhout, Alexandre M J J Bonvin, et al.
Plos One|June 23, 2011
Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trialElske J M van Gils, Eelko Hak, Reinier H Veenhoven, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2009
Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcomeAngelique G S C Jansen, Gerwin D Rodenburg, Arie van der Ende, et al.
Vaccine|November 26, 2009
Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 dosesGerwin D Rodenburg, Elske J M van Gils, Reinier H Veenhoven, et al.
JAMA|July 9, 2009
Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trialElske J M van Gils, Reinier H Veenhoven, Eelko Hak, et al.
JAMA|September 9, 2010
Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strainsElske J M van Gils, Reinier H Veenhoven, Eelko Hak, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Infection and Immunity|October 24, 2003
Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation formThomas A Luijkx, Harry van Dijken, Hendrik-Jan Hamstra, et al.
Vaccine|September 15, 2004
Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteinsMarien I de Jonge, Hendrik Jan Hamstra, Wim Jiskoot, et al.
European Journal of Biochemistry|October 24, 2002
Conformational analysis of opacity proteins from Neisseria meningitidisMarien I de Jonge, Martine P Bos, Hendrik J Hamstra, et al.
Journal of Medical Microbiology|April 6, 2001
Influence of infection of cells with bacteria associated with reactive arthritis on the peptide repertoire presented by HLA-B27Jeffrey H Ringrose, Anton O Muijsers, Yvonne Pannekoek, et al.
Journal of Molecular Biology|May 6, 2003
Immunogenicity of peptide-vaccine candidates predicted by molecular dynamics simulationsClasien J Oomen, Peter Hoogerhout, Alexandre M J J Bonvin, et al.
Plos One|June 23, 2011
Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trialElske J M van Gils, Eelko Hak, Reinier H Veenhoven, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2009
Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcomeAngelique G S C Jansen, Gerwin D Rodenburg, Arie van der Ende, et al.
Vaccine|November 26, 2009
Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 dosesGerwin D Rodenburg, Elske J M van Gils, Reinier H Veenhoven, et al.
JAMA|July 9, 2009
Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trialElske J M van Gils, Reinier H Veenhoven, Eelko Hak, et al.
JAMA|September 9, 2010
Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strainsElske J M van Gils, Reinier H Veenhoven, Eelko Hak, et al.
Pageof 4